Search
for
Sort by
Research 151–180 of 787
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- Baricitinib for the Treatment of Alopecia Areata
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
- Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways
- Janus kinase inhibitors for alopecia areata: A narrative review
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- A new era for alopecia areata: New treatments and improved knowledge of the condition
- JAK Family Expression and Therapeutic Implications in Primary Cicatricial Alopecias
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- Dysregulation of Leukaemia Inhibitory Factor (LIF) Signalling Pathway by Supraphysiological Dose of Testosterone in Female Sprague Dawley Rats During Development of Endometrial Receptivity
- 290 Brepocitinib improves cicatricial alopecia and downregulates key T-helper biomarkers
- Hair growth–promoting effects of Enz_MoriL on human dermal papilla cells through modulation of the Wnt/β-Catenin and JAK-STAT signaling pathways
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- 0480 Upadacitinib monotherapy for treatment of pyoderma gangrenosum: A case series
- Baricitinib Demonstrates Rapid Action Within Just 2 Months of Treatment in Severe and Unresponsive Alopecia Areata: A Case Report
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Alopecia Areata of the Nails: Diagnosis and Management
- Baricitinib in pediatric chronic immune thrombocytopenia and associated autoimmune conditions: a case report
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring
- Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient